Nyxoah Aktie

2,69 EUR +0,08 EUR +2,87 %

22:13:43

BMN

3,17 USD -0,07 USD -2,16 %

20:59:50

BTT

Nyxoah jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.120,51 Mio. EUR

Div. Rendite0,00%

WKNA2QCWK

ISINBE0974358906

SymbolNYXH

Nyxoah Aktien News

Sortieren:Datum Meistgelesen

20.03.26MotleyFoolNyxoah (NYXH) Q4 2025 Earnings Call Transcript

19.03.26ZacksNyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates

01.12.25ZacksNyxoah Gains Favorable CMS Reimbursement Ruling for Genio System

WerbungNyxoah-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

13.11.25ZacksNyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates

13.11.25MotleyFoolNyxoah (NYXH) Q3 2025 Earnings Call Transcript

29.10.25ZacksAnalysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for

07.10.25ZacksNyxoah Shares Rise on First U.S. Commercial Use of Genio System

02.10.25ZacksNyxoah Expands in the Middle East to Provide Wider Access to Genio

15.09.25EQS GroupEQS-News: Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

18.08.25MotleyFoolNyxoah (NYXH) Q2 2025 Earnings Call Transcript

18.08.25MotleyFoolNyxoah Q2 Revenue Jumps 74 Percent

18.08.25EQS GroupEQS-News: Nyxoah Reports Second Quarter Financial and Operating Results

15.08.25ZacksNyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

11.08.25EQS GroupEQS-News: Nyxoah Announces Preliminary Results for the Second Quarter of 2025

08.08.25EQS GroupEQS-News: Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

28.07.25EQS GroupEQS-News: Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

13.06.25GlobeNewswireInvitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025

30.05.25GlobeNewswirePublication relating to transparency notifications

28.05.25GlobeNewswireNyxoah to Present at the Jefferies Global Healthcare Conference

23.05.25GlobeNewswireInformation on the total number of voting rights and shares

14.05.25ZacksNyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates

14.05.25EQS GroupEQS-News: Nyxoah Reports First Quarter Financial and Operating Results

14.05.25GlobeNewswireNyxoah Reports First Quarter Financial and Operating Results

12.05.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

09.05.25GlobeNewswirePublication relating to transparency notifications

09.05.25GlobeNewswireInvitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025

07.05.25GlobeNewswireNyxoah to Release First Quarter 2025 Financial Results on May 14, 2025

16.04.25GlobeNewswireConditional Issuance of Shares

15.04.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

08.04.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

08.04.25EQS GroupEQS-News: Nyxoah Provides Update on FDA Approvable Letter for Genio System

08.04.25GlobeNewswireNyxoah Provides Update on FDA Approvable Letter for Genio System

31.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

26.03.25EQS GroupEQS-News: FDA Issues Nyxoah an Approvable Letter for its Genio® System

26.03.25GlobeNewswireFDA Issues Nyxoah an Approvable Letter for its Genio® System

13.03.25EQS GroupEQS-News: Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

13.03.25GlobeNewswireNyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

10.03.25GlobeNewswireNyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

03.03.25GlobeNewswireNyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

19.02.25EQS GroupEQS-News: Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Nyxoah News

Nyxoah News: auf dieser Seite finden Sie alle Nyxoah News und Nachrichten zur Nyxoah Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Nyxoah News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Nyxoah News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.